Following the success of Tropical Medicine 2019 pulsus LTD is pleased to announce “5th World Congress on
Advances in Tropical Medicine and Infectious Diseases” held during June 17-18, 2019, Paris, France. We are happy to invite all anticipated participants to share and explore their research findings as keynote presentations, Oral talks, Poster presentations, Workshops and Exhibitions.
Why to attend?
With members from around the world focused on learning about Emerging Innovative Treatment & Therapeutic Techniques in Medical and Infectious Diseases, this is your best opportunity to reach the largest assemblage of participants from the Tropical Medicine & Infectious diseases community. This particular conference conduct Presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World’s eminent speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.
PULSUS LTD is an open resource platform that conducts 3000+ global events including International Conferences, Workshops, Symposia, Trade Shows, Exhibitions and Science Congresses in all the major scientific disciplines, including Clinical, Medical, and pharmaceutical, Engineering, Technology, Business Management and Life Sciences across America, Europe, The Middle East, and Asia Pacific. It is reaching over 25 million researchers, scholars, students, professionals and corporate entities all over the globe.
Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
Infectious Diseases Researchers, Scientists, Faculties, Students
Infectious Diseases Associations and Societies
Pharmaceutical Companies and Industries
Medical Devices Manufacturing Companies
Drug Manufacturing Companies and Industries
Laboratory Technicians and Diagnostic Companies
Business Entrepreneurs and Industrialists
For Scientific Sessions please go through the link: https://infectiousmeet.conferenceseries.com/call-for-abstracts.php
For Abstract Submission please go through the link: https://tropical.cmesociety.com/
Track 01: Types of Infectious Diseases
The diseases which are caused by germs and which may affect any part of the body are called infectious diseases.They are caused by pathogenic microorganisms such as bacteria, virus, parasites and fungi. Germs can spread by direct or indirect contact. Vaccination, maintenance of proper hygiene and medicines help in the prevention of infection.
Track 02: Causes and Symptoms of Infectious Diseases
Infectious diseases can be caused by bacteria, virus, fungi and parasites through direct contact, indirect contact, insect bites and food contamination. Each infectious disease has its own specific signs and symptoms. General signs and symptoms are common to a number of infectious diseases which includes fever, diarrhoea, fatigue and muscle aches.
Track 03: Global Trends in Emerging Infectious Diseases
An Infectious disease whose occurrence has increased in the past years or threatens to increase is termed as emerging. These diseases include new infections, previously unrecognized infections and old infections reappearing due to antimicrobial resistance, public health issues and unhygienic conditions.
Track 04: Microbial Pathogenesis and Virulence
Microbial pathogenesis is the study of molecular mechanisms of microorganisms to cause disease in humans and animals. By understanding how pathogens cause disease helps in the development of new therapeutic approaches. Virulence is the measure of the pathogenicity of an organism. The degree of virulence is related directly to the ability of the organism to cause infection despite host resistance mechanisms, it is affected by numerous variables such as the number of infecting bacteria, route of entry into the body, specific and nonspecific host defence mechanisms and virulence factors of the bacterium.
Track 05: Immunology of Infections
Immunology of infections means the battle between pathogens and the host immune defences. Immunology is the branch of science which is concerned with various aspects related to immune system, innate and acquired immunity. Immunology also deals with laboratory techniques involving the interaction of antigens with specific antibodies.
Track 06: Mechanism of Resistance
Mechanism of resistance towards antimicrobials by microorganisms includes enzymatic destruction, enzymatic modification, altered target and decreased uptake. Mechanism of resistance is due to the inactivation or modification of antibiotics, an alteration in the target site of the antibiotic that reduces its binding capacity, the modification of metabolic pathways to circumvent the antibiotic effect and the reduced intracellular antibiotic accumulation by decreasing permeability and/ or increasing active efflux of the antibiotic.
Track 07: Antimicrobial/ Antibiotic/ Antibacterial Resistance
Antimicrobial/ antibiotic/ antibacterial resistance is the ability of microorganisms to resist the effects of drugs that means diseases causing germs do not get killed and their growth is not stopped. Antibiotic resistant infections are of greater risk which cannot be avoided completely. Infections with resistant organisms are difficult to treat requiring costly and sometimes toxic alternatives.
Track 08: Antimicrobial/ Antibiotic/ Antibacterial Stewardship
Antimicrobial/ antibiotic/ antibacterial stewardship promotes the appropriate use of antimicrobials which improves patient outcomes reduces microbial resistance and decreases the spread of infections caused by multidrug resistant organisms.
Track 09: Epidemiology of Emerging and Re-Emerging Infectious Diseases
Epidemiology studies the patterns, causes and effects of health and disease conditions. It is the cornerstone of public health and informs policy decisions and evidence based practice by identifying risk factors for disease and targets for preventive healthcare. Epidemiologists help with study design, data collection, statistical analysis of data, interpretation and dissemination. Epidemiology helped to develop methodology used in clinical research, public health studies and to a lesser extent basic research in the biological sciences.
Track 10: Diagnosis of Infectious Diseases
Medical diagnosis is the process of determining which disease or condition explains a person's symptoms and signs. Laboratory tests may identify organisms directly (e.g., visually, using a microscope growing the organism in culture) or indirectly (e.g., identifying antibodies to the organism). General types of tests include microscopy, culture and immunologic tests (agglutination tests such as latex agglutination, enzyme immunoassays, western blot, precipitation tests and complement fixation tests) and nucleic acid/ non nucleic acid based identification methods. Sub types of diagnoses include clinical, laboratory, radiology, principal and admitting diagnosis. Advanced methods have been implemented to diagnose the infection in any part of the body. Examples include biomarkers/ elisa test/ chest x ray/ skin biopsy/ tympanometry and tympanocentesis.
Track 11: Treatment for Infectious Diseases
Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Yeast infections can be primarily treated by sterilisation methods. Parasitic infections can be treated by antiparasitic drugs. Diseases such as cancer can be treated by chemotherapy. Recent techniques have proved that there is no disease that cannot be treated.
Track 12: Infectious Diseases Prevention, Control and Cure
Infectious diseases prevention and control is helpful to prevent the transmission of infectious diseases. Aseptic technique is normally applied to prevent the infections caused by different means. Sterilization is another process of killing microorganisms by the application of heat. Disinfection is the process of killing harmful microorganisms. Some infectious diseases can be prevented by avoiding direct contact with the contagious person. Infections can also be controlled and prevented by creating public awareness on various infectious diseases and their outbreaks. Infections can be cured by various antimicrobials.
Track 13: Antimicrobials/ Antibiotics/ Antibacterials
Antimicrobials/ antibiotics/ antibacterials are the drugs used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. Few antibiotics possess antiprotozoal activity. Antibiotics are not effective against viruses such as the common cold or influenza and their inappropriate use allows the emergence of resistant organisms.
Track 14: Vaccines and Vaccination
Vaccines are the products that are able to produce immunity from a disease and can be administered through needle injections, by mouth and by aerosol. Vaccination is the injection of a killed or weakened organism that produces immunity in the body against that organism.
Track 15: Infectious Diseases Vaccines
Infectious diseases vaccines are the vaccines which prevent the infectious diseases and infectious diseases like diphtheria, haemophilus influenzae serotype b infection, hepatitis b, measles, meningitis, mumps, pertussis, poliomyelitis, rubella, tetanus, tuberculosis and yellow fever are preventable through vaccines.
Track 16: Sexually Transmitted Diseases/ Sexually Transmitted Infections
Sexually transmitted diseases/ sexually transmitted infections are the infectious diseases which are transmitted through sexual contact with an infected individual and also transmitted during vaginal or other types of sexual intercourse including oral and anal sex.
Track 17: Pediatric Infectious Diseases/ Childhood Infectious Diseases
Pediatric infectious diseases/ childhood infectious diseases are the infectious diseases which are caused in children of different age groups. Pediatric infectious diseases specialist’s takes care of the infections occurring in children and the treatment methods vary for children from adults.
Track 18: Neuro Infectious Diseases
Neuro infectious diseases are the infectious diseases which are observed in the nervous system. Viral and immune mediated disorders of the nervous system are among the most challenging neurological disorders. The most common neuro immune disorder is multiple sclerosis and hiv is the most common viral infection of the nervous system.
Track 19: Noscomial Infections/ Hospital Acquired Infections/ Health Care Associated Infections
Nosocomial infections/ hospital acquired infections/ health care associated infections are the infections that are contracted from the environment or staff of a healthcare facility and they spread in the hospital environment, nursing home environment, rehabilitation facility and clinic or other clinical settings.
Infectious Diseases Therapeutic Market
The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. Current market trend shows that North America has the more global market for infectious diseases therapeutics due to increasing incidence of infectious diseases and due to rise in aging population. Followed by North America highest global market is expected in Asia then followed by the Europe in the global infectious diseases therapeutics market. In Asia-Pacific region, China and India are expected to be the fastest growing infectious diseases therapeutics markets. The main reasons behind the highest global market of infectious diseases therapeutics market in the above countries is mainly due to large number of patients and due to increase in government funding. Some of the major companies playing a key role in the global infectious diseases therapeutics market are Merck & Co., Pfizer, Johnson & Johnson, F. Hoffmann-La Roche, GlaxoSmithKline Pharmaceutical, Inc., Auritec Pharmaceuticals, Novartis, Achillion Pharmaceuticals, Isis Pharmaceuticals and Gilead Sciences.
Infectious Diseases Diagnostics Market
Market for infectious disease molecular diagnostics tests includes hospitals, blood banks, reference laboratories. North America has the highest global market for molecular diagnostics tests followed by Europe due to the market availability of the tests and high occurrence rate of various infectious diseases such as HPV, hepatitis and bacterial infections. Asia Pacific, Latin America and Middle East are expected to be the potential markets in the coming years. Major companies which play a key role in infectious disease molecular diagnostics tests market are Abbott Laboratories, Affymetrix, Inc., Becton, Dickinson and Company, bioMérieux, Cepheid, Inc., Hologic, Inc., Life Technologies, Myriad Genetics, Inc., Qiagen N.V. and others.
The deadliest Ebola outbreak in recorded history is happening right now. The outbreak is unprecedented both in the number of cases and in its geographic scope. And so far, it doesn't look like it's slowing down.
The outbreak has now hit three countries: Guinea, Sierra Leone, and Liberia. And the virus — which starts off with flu-like symptoms and often ends with horrific hemorrhaging — has infected about 600 people and killed an estimated 367 since this winter, according to the numbers on June 26 from the World Health Organization.
Members associated with Infectious Diseases
- Centre for Infectious Diseases and Policy includes 218 members
- Global Public Health is having 106913 members
- Members Pediatric Infectious Disease and Immunology has 3291 members
- European Society of Clinical Microbiology and Infectious Diseases has 3438 members
- Infectious Diseases Society has 707 members
- Worldwide members of Infectious are 3,683 members
- European Congress in Clinical Microbiology and Infectious Diseases is having 1,369 members
- National Foundation for Infectious Diseases has 365 members
- UNC Institute for Global Health & Infectious Diseases has237 members
- Cirion; bridging the gap in infectious diseases between science and society has55 members
- HIV/AIDS & Infectious Diseases has 85 members
- M.S. in Public Health Microbiology & Emerging Infectious Diseases has 44 members
- Infectious Diseases and Public Health (IDPH) Research Group has 45 members
- EUPHA Section Infectious diseases control has 38 members
- Center for Structural Genomics of Infectious Diseases (CSGID) has30 members
- LSHTM_Control of Infectious Diseases has 19 members
Societies and Associations related to Infectious Diseases
- Healthcare Infection Society
- European Society for Pediatric Infectious Diseases
- European Society of Clinical Microbiology and Infectious Diseases
- Infection Prevention Society
- British Society for Immunology
- British Infection Association
- British Infection Association
- European Society for pediatric Infectious diseases
- Health care Infection Society
- Worldwide societies for infectious diseases is about 150
Universities related to Infectious Diseases
- University of Cambridge
- Kings College of London
- London School of Hygiene and Tropical Medicine
- Imperial College London
- UCL Institute of Epidemiology and Health care
- University of Sheffeild
- Pediatric Infectious Diseases Society
- Columbia University
- University of Maryland
- Swedish Institute for Infectious Disease Control
- Uppsala University
- University of Gothenburg
- University of Otago
- Oslo University
- University of Pittsburgh
- Emory Health Sciences
- Queensland University of Technology
- University of Liverpool
- University of Colorado Denver
- Infectious Diseases Society of America
- Medical College of Georgia at Georgia Regents University
- http://www.mayoclinic.org/diseases-conditions/infectious-diseases/basics/definition/con- 20033534
- Murray JM, Law MG, Gao Z, Kaldor JM. The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users. Int J Epidemiol 2003;32: 708–14.
- Law MG, Dore GJ, Bath N et al. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. Int J Epidemiol 2003;32:717–24.
- Lederberg J, Shope RE (eds). Emerging Infections: Microbial Threats to Health in the United States. Washington, DC: National Academy Press, 1992.
- Watts S. Epidemics and History: Disease, Power and Imperialism.New Haven, Conn: Yale University Press; 1997
- Lee HSJ, ed. Dates in Infectious Diseases. Boca Raton, Fla: The Parthenon Publishing Group; 2000.
- Fears JR. The plague under Marcus Aurelius and the decline and fall of the Roman Empire. Infect Dis Clin North Am. 2004;18:65–77.
- Antonine plague. Wikipedia Web page. Available at: http://en.wikipedia.org/wiki/Antonine_Plague. Accessed Feb 22, 2006.
- Porter R, ed. Cambridge Illustrated History of Medicine. New York, NY: Cambridge University Press; 1996.
- Rosen G. A History of Public Health. Baltimore, Md: Johns Hopkins University Press; 1993.
- McNeill WH. Plagues and Peoples.New York, NY: Doubleday; 1977.
- Hirst LF. The Conquest of Plague. London, England: Oxford University Press; 1953.
- Duncan SR, Scott S, Duncan CJ. Reappraisal of the historical selective pressures for the CCR5-Delta32 mutation. J Med Genet. 2005; 42:205–208.